VentriJect logo — Reliable estimate of cardiorespiratory fitness (VO2max) - in...

VentriJect

Reliable estimate of cardiorespiratory fitness (VO2max) - in less than 3 minutes

Founded 2018 Denmark Denmark 13 employees Series A Total: $12.00M

General Information

Company Name VentriJect
Founded Year 2018
Location Denmark Denmark
Employees 13
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with VentriJect. To contact VentriJect, visit ventriject.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About VentriJect

VentriJect is a Denmark-based startup that aims to revolutionize the evaluation of cardiorespiratory fitness with its flagship product, Seismofit. Founded in 2018 as a spin-out from Aalborg University, VentriJect has garnered attention for its groundbreaking approach to estimating cardiorespiratory fitness, also known as VO2max. This technology holds immense potential as it offers high accuracy, requires no specialized training, and can estimate VO2max in less than 3 minutes. The recent kr12.00M Series A investment on 12 August 2021 from Vaekstfonden and Investo Capital signifies growing confidence in VentriJect's innovative solution within the healthcare industry. With its focus on addressing the challenges associated with existing evaluation methods and its strong backing from notable investors, VentriJect is poised to make a significant impact in the field of cardiorespiratory fitness assessment.

Taxonomy: cardiorespiratory fitness, VO2max, Seismofit, medical device, respiratory fitness measurement, clinical validation, health improvement, cardiology, health check-up, spin-out from research center, innovation, startup, health indicator

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A kr12.00M 2
Vaekstfonden, Investo Capital
12 Aug 2021

VentriJect Alternatives & Competitors

VentriJect vs
LARALAB
LARALAB Germany

Deep Learning powered platform for heart valve interventions.

23 employees
Analytics
VentriJect vs
HatiSens
HatiSens Australia

Faster heart attack detection to guide clinical treatment.

2 employees
Health Care, Manufacturing
VentriJect vs
LENTECHS
LENTECHS United States

Developing a new generation of soft, suspended contact lens

Venture round
9 employees
Biotechnology, Health Care

FAQ About VentriJect

Reliable estimate of cardiorespiratory fitness (VO2max) - in less than 3 minutes
VentriJect was founded in 2018.
VentriJect is headquartered in Denmark.
VentriJect has approximately 13 employees.
VentriJect has completed 1 funding round, raising a total of $12.00M. The latest funding stage is Series A.
Top alternatives and competitors to VentriJect include LARALAB, HatiSens, LENTECHS, Coherex Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VentriJect and LARALAB are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for VentriJect, https://bouncewatch.com/company/ventriject, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes